Navigation Links
Coherent, Inc. Announces Termination of SEC Informal Inquiry
Date:7/10/2008

SANTA CLARA, Calif., July 10 /PRNewswire-FirstCall/ -- Coherent, Inc. (Nasdaq: COHR), today announced that the Securities and Exchange Commission has formally notified the Company that its investigation of Coherent's historical stock option granting practices has been terminated and that it will not recommend any enforcement action.

Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4161. For more information about Coherent, visit the Company's Web site at http://www.coherent.com/ for product and financial updates.


'/>"/>
SOURCE Coherent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Coherent, Inc. to Webcast Fourth Fiscal Quarter 2007 Results
2. Coherent, Inc. Receives Expected Letter from NASDAQ
3. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
4. Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets
5. Vasogen Announces Second Quarter 2008 Results
6. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
7. ULURU Inc. Announces Update on Recent Development
8. Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
9. Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
10. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
11. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
(Date:2/4/2016)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... held February 8-9, 2016, at the Waldorf Astoria New ... Healthcare Conference, taking place in New York ... Sapirstein , Chief Executive Officer of ContraVir, will provide ...
(Date:2/4/2016)... ... 2016 , ... Franz Inc. , an early innovator ... been recognized As “ Best in Semantic Web Technology - USA & Leader ... it’s our priority to showcase prominent professionals who are excelling in their industry ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
Breaking Biology Technology:
(Date:2/4/2016)... The field of Human Microbiome research ... popular hubs of the biotechnology industry. While the ... of human microbiota, have garnered a lot of ... space has literally exploded in terms of both ... focuses on biomedical aspects of research, development, and ...
(Date:2/3/2016)... Calif. , Feb. 3, 2016 Vigilant ... Police Department in Missouri ... license plate reader (LPR) data from Vigilant Solutions. ... hit-and-run case in which the victim was walking out of a convenience ... parking space next to his vehicle, striking his vehicle ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... analysis of the bioinformatic market by reviewing the ... computer enabled tools that drive the field forward. ... report to: Identify the challenges and opportunities ... service providers and software solution developers, as well ...
Breaking Biology News(10 mins):